Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleResearch and Reports

Development of a Procedure to Resolve Daratumumab Interference in Pretransfusion Testing

Kaitlin Walsh, Tara C. Moon, Troy Dang and Caroline Immel
American Society for Clinical Laboratory Science April 2023, DOI: https://doi.org/10.29074/ascls.2020002600
Kaitlin Walsh
University of North Carolina at Chapel Hill
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tara C. Moon
University of North Carolina at Chapel Hill
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Troy Dang
UNC Health Care
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Immel
UNC Health Care
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    Summary of antibody screening of patients treated with DARA





    Patient
    Antibody Screen With Untreated Reagent Cells (AHG Phase)Antibody Screen With DTT-treated Reagent Cells (AHG Phase)



    Autocontrol
    1SC I1+SC INegativeNegative
    SC II1+SC IINegative
    SC III1+SC IIINegative
    2SC I1+SC INegativeNegative
    SC IINegativeSC IINegative
    SC III1+SC IIINegative
    3SC INegativeSC INegativeNegative
    SC IIWeakSC IINegative
    SC III1+SC IIINegative
    4SC I1+SC INegativeNegative
    SC II1+SC IINegative
    SC III1+SC IIINegative

    SC, screening cell.

      • View popup
      Table 2.

      Quality-control results with anti-K, 45-minute incubation with DTT

      Anti-K PlusReactionInterpretation
      Positive control (K+k+)4+Positive
      Negative control (K−k+)0Negative
      DTT-treated SC II (K+k+)0Negative

      SC, screening cell.

        • View popup
        Table 3.

        Quality-control results with anti-K, 30-minute incubation with DTT

        Anti-K PlusReactionInterpretation
        Positive control (K+k+)3+Positive
        Negative control (K−k+)0Negative
        DTT-treated SC II (K+k+)WeakPositive

        SC, screening cell.

          • View popup
          Table 4.

          Reagent cost breakdown


          Reagent

          Reagent Cost
          Unit
          Volume (mL)
          Drops
          per Unit
          Cost
          per Drop
          Number
          of Drops Used
          Volume
          Used (mL)

          Total Cost
          DTT$53.58240$1.4012N/A$16.80
          SC I$60.0010200$0.307N/A$2.10
          SC II$60.0010200$0.307N/A$2.10
          SC III$60.0010200$0.307N/A$2.10
          PEG$21.0010200$0.1114N/A$1.47
          Anti-immunoglobulin G$28.5010200$0.1414N/A$1.96
          Check cells$32.0010200$0.163N/A$0.48
          Anti-K antisera$250.005100$2.503N/A$7.50
          K+ panel cell$30.005100$0.301N/A$0.30
          K− panel cell$30.005100$0.301N/A$0.30
          PBS$20.001000N/AN/AN/A226$5.42
          TotalN/AN/AN/AN/AN/AN/A$40.53

          N/A, not applicable; SC, screening cell.

            • View popup
            Table 5.

            Supply cost breakdown

            SupplyCost per Individual
            Supply

            Number of Supplies Used

            Total Cost
            12×75-mm test tubes$0.0213$0.26
            Transfer pipets$0.0321$0.63
            TotalN/AN/A$0.89

            N/A, not applicable.

            PreviousNext
            Back to top

            In this issue

            American Society for Clinical Laboratory Science: 37 (2)
            American Society for Clinical Laboratory Science
            Vol. 37, Issue 2
            1 Apr 2024
            • Table of Contents
            • Index by author
            Print
            Download PDF
            Article Alerts
            Sign In to Email Alerts with your Email Address
            Email Article

            Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

            NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

            Enter multiple addresses on separate lines or separate them with commas.
            Development of a Procedure to Resolve Daratumumab Interference in Pretransfusion Testing
            (Your Name) has sent you a message from American Society for Clinical Laboratory Science
            (Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
            CAPTCHA
            This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
            Citation Tools
            Development of a Procedure to Resolve Daratumumab Interference in Pretransfusion Testing
            Kaitlin Walsh, Tara C. Moon, Troy Dang, Caroline Immel
            American Society for Clinical Laboratory Science Apr 2023, DOI: 10.29074/ascls.2020002600

            Citation Manager Formats

            • BibTeX
            • Bookends
            • EasyBib
            • EndNote (tagged)
            • EndNote 8 (xml)
            • Medlars
            • Mendeley
            • Papers
            • RefWorks Tagged
            • Ref Manager
            • RIS
            • Zotero
            Request Permissions
            Share
            Development of a Procedure to Resolve Daratumumab Interference in Pretransfusion Testing
            Kaitlin Walsh, Tara C. Moon, Troy Dang, Caroline Immel
            American Society for Clinical Laboratory Science Apr 2023, DOI: 10.29074/ascls.2020002600
            Twitter logo Facebook logo Mendeley logo
            • Tweet Widget
            • Facebook Like
            • Google Plus One

            Jump to section

            • Article
              • ABSTRACT
              • INTRODUCTION
              • MATERIALS AND METHODS
              • RESULTS
              • DISCUSSION
              • CONCLUSION
              • Acknowledgments
              • Footnotes
              • References
            • Figures & Data
            • Info & Metrics
            • PDF

            Related Articles

            • No related articles found.
            • Google Scholar

            Cited By...

            • No citing articles found.
            • Google Scholar

            More in this TOC Section

            • Barriers to Implementation of Quality Management Systems in Laboratories: Lessons from the Southern Africa TB Health Systems Project
            • Polyagglutination: Lectin Isolation for T-Activated Red Cells
            • Strength of Direct Antiglobulin Test as an Indicator of Disease Severity in Autoimmune Hemolytic Anemia
            Show more Research and Reports

            Similar Articles

            Keywords

            • AABB - American Association of Blood Banks
            • ADCC - antibody-dependent cellular cytotoxicity
            • AHG - antihuman globulin
            • CDC - complement-dependent cytotoxicity
            • DARA - daratumumab
            • DTT - dithiothreitol
            • FDA - Food and Drug Administration
            • PBS - phosphate-buffered saline
            • PEG - polyethylene glycol
            • TAT - turnaround time
            • TMS - transfusion medicine services
            • UNC - University of North Carolina
            • antigen-antibody reactions
            • transfusion medicine
            • blood bank/methods
            • quality control

            © 2025 The American Society for Clinical Laboratory Science

            Powered by HighWire